Skip to main content

Biotech Companies Invest Microfluidic Device Development for Pathogen Detection

 Emerging COVID-19 variants have encouraged many biotech giants to actively participate in developing microfluidic devices for rapid and accurate SARS-CoV-2 detection.

 

Though the current global wave of the omicron COVID-19 variant is relatively mild in terms of causing severe disease and death, it's necessary to continuously develop new technologies and strategies to identify and resist COVID-19 infection in case more aggressive variants may come around from nowhere. Microfluidics, a highly miniaturized, automatic, and integrated technology, is expected to perform rapid, low-cost, accurate, and point-of-care detection of infectious diseases like COVID-19. Researchers from leading life science companies like Creative Biolabs have gotten involved in developing and designing microfluidic devices for different applications, including devices for quick and accurate SARS-CoV-2 detection.

 

Microfluidic Chips for Pathogen Detection

 

Infectious diseases arise from pathogens, including bacteria, viruses, and parasites, with global distribution and transmission between individuals. Scientists have developed some disposable microfluidic chips that can detect pathogens simply with drops of biological fluids, such as saliva, blood, sweat, and urine. For instance, a microfluidic chip can accurately detect the SARS-CoV-2 virus with a few drops of saliva with fluorescent antibodies against the virus, whose accuracy could be comparable to the gold-standard test, PCR.

 

Besides the SARS-CoV-2 virus, the microfluidic chips are versatile in manipulating and detecting many other pathogens, including seasonal coronavirus, HIV, influenza viruses, the Zika virus, H1N1 influenza virus, and even microorganisms like Legionella and E. coli. Moreover, microfluidic chips have also been combined with traditional methods like PCR, RT-PCR, qPCR, RT-LAMP due to simplicity in function and fabrication, rapid turnaround time, decreased reagent consumption, reduced contamination, etc.

 

Driven by the rapid advancements of technology, digital microfluidic devices for molecular diagnostics have become attractive and promising tools to deal with the severe COVID-19 pandemic as well as diseases caused by other pathogens.

 

The increasing need of adopting cutting-edge microfluidic-based tools has encouraged life science companies like Creative Biolabs to be dedicated to providing one-stop solutions to microfluidic chip development and design, especially microfluidic chips for tumor marker detection, viruses detection, and fungal infections. Several automatic and portable microfluidic platforms have been established for single-cell analyses, molecular diagnostics, DNA sequencing, PCR amplification, amino acid/peptide/protein analysis, immunoassays, cell sorting, manipulation, and so on.

 

About the Author

 

Vivian is a biotechnology beat reporter exploring the cutting edge of microfluidic analysis. To find out more about microfluidic chips, click here.

Labels:

Comments

Post a Comment

Popular posts from this blog

Primary Antibody vs. Secondary Antibody, How to Choose?

  Antibodies (or immunoglobulins) are Y -shaped glycoproteins released by the immune system  to detect and bind to "foreign" substances , known as " antigens ", triggering a cascade of actions to destroy these foreign invaders. Scientists would develop different antibodies for research use, which basically can be classified into primary and secondary antibodies . However, how to choose the right type of antibodies for different immunoassays in experiment procedures, such as western blotting (WB), enzyme-linked immunosorbent assays (ELISA), and immunoprecipitation (IP), is one of the most common questions for green hands in the laboratory.   P rimary A ntibod y vs. Secondary Antibody   Antibodies could be categorized into two types based on the binding capability and experimental applications— primary   antibodies   and  secondary antibodies.   The main difference between these two types of antibodies is that primary antibody binds specifically to ...
Post a Comment
Read more

How Haptens Differ from Antigens and Become Immunogens?

The  difference between antigens vs. haptens  is one the most concerning issues for people who are not familiar with them. As a matter of fact, antigens and haptens are similar in many ways. They are both molecules triggering immune responses and acting as antigenic agents. And they both work as immunogens and bind to antibodies although haptens in a different manner.   What distinguishes an antigen mostly from a hapten is that antigens are complete molecules spontaneously triggering immune response whereas haptens are fragmentary small molecules that are unable to elicit immune responses unless they are conjugated to a larger molecule, known as a carrier.   What are Antigens? Antigen s, including proteins, peptides, and polysaccharides, are immunogen   molecules  that can trigger immune response s or naturally bind to   immune   components . An antigen may have one or more epitopes, which are the determinants of recognition and binding to antibod...
Post a Comment
Read more

Single-cell Genomics Study Elucidates Human Cytomegalovirus Infection

  I nfection of β-herpesvirus h uman cytomegalovirus (HCMV) could be life-threatening or cause life-long suffering in the majority of humans. Moreover, the viral vertical transmission during pregnancy leads to most congenital birth defects. However, treatment and prevention options currently available are extremely   limited.   Challenges  in Studying HCMV–host Cell Interactions   More than 235 kbp of double-stranded DNA (dsDNA)  in HCMV make s the largest known genome of human herpesviruses. Besides, HCMV is similar to other herpesviruses with complicated transcriptional architecture, including alternative transcription start sites, alternative splicing events, and polycistronic transcripts. The complex transcriptional architecture enables strict temporal control of gene expression and the possibility of generating multiple distinct proteins from a single genomic locus. The complexity is further increased by host cellular heterogeneity and differences in i...
Post a Comment
Read more